Startup offers genetic testing that promises to predict healthiest embryo
Aurea toddles around in her pink sparkly sneakers, climbing up the steps that, to her, are nearly waist high. Her tiny t-shirt is the epitome of how adorable she is. It says “you + me + snuggles.” Aurea’s father, Rafal Smigrodzki, watches over his little girl. He is clearly proud of her. “She’s very lively. I think she’s a pretty, pretty happy baby,” Smigrodzki said, “a very often smiley baby.”
Of course, Smigrodzki thinks his baby is special — most parents do. But Aurea is indeed unique. She was born almost two years ago and happens to be the first child born as the result of a new type of genetic screening, which carefully selected her embryo. Smigrodzki and his girlfriend used in vitro fertilization and an advanced selection process from a startup called Genomic Prediction.
The New Jersey startup offers genetic tests and promises to help prospective parents select embryos with the best possible genes. The company says its test can screen embryos for a variety of diseases and health conditions, like heart disease, diabetes, or breast cancer.
Smigrodzki, a neurologist with a PhD in genetics, stumbled across the company in 2017.
“I was always interested and reading about all kinds of new developments,” he said. “And just happened to read an article in the MIT Technology Review about Genomic Prediction.”
Post a Comment